Isabelle Hoche
About Isabelle Hoche
Isabelle Hoche serves as the Head of European Regulatory Affairs at AlloVir since 2021, bringing extensive experience in regulatory roles within the pharmaceutical industry.
Current Role at AlloVir
Isabelle Hoche serves as the Head of European Regulatory Affairs at AlloVir, a position she has held since 2021. Based in Paris, Île-de-France, France, she oversees regulatory strategies and compliance for the company's operations in Europe. Her role involves ensuring that AlloVir's products meet the regulatory requirements of various European markets.
Education and Qualifications
Isabelle Hoche obtained her Doctor of Pharmacy (PharmD) from Université de Montpellier. Additionally, she is pursuing a Master 2 (M2) in International Regulations on Drugs at Université Lille 1 Sciences et Technologies, a program she has been engaged in since 1995. Her extensive education provides a strong foundation for her work in regulatory affairs.
Professional Background
Prior to her current position, Isabelle Hoche accumulated significant experience in regulatory affairs. She worked at Gilead Sciences as Regulatory Affairs Director for France from 2009 to 2016 and later as International Regulatory Lead from 2017 to 2021. Her earlier career includes a 13-year tenure at Bristol-Myers Squibb as Directeur Affaires Reglementaires from 1996 to 2009.
Experience at Gilead Sciences
During her time at Gilead Sciences, Isabelle Hoche held two key positions. As Regulatory Affairs Director for France, she managed local regulatory submissions and compliance. In her role as International Regulatory Lead, she coordinated regulatory strategies across multiple countries, enhancing Gilead's global presence in the pharmaceutical market.
Long-term Commitment to Education
Isabelle Hoche's commitment to education spans over two decades. She studied pharmacy at Université Montpellier I, achieving her Doctor of Pharmacy (Pharm.D.) between 1980 and 2000. Her ongoing studies in international regulations demonstrate her dedication to staying current in the evolving field of regulatory affairs.